MedTrace Logo

A Case Series of VPIA Using Remifentanil for Labour and Delivery

NCT02122705 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2017-02-07

No results posted yet for this study

Summary

This study is a prospective case series aiming to evaluate a new VPIA remifentanil algorithm which would benefit labouring mothers who are unable or unwilling to receive epidural analgesia.

Conditions

  • Labor Pain

Interventions

DEVICE

VPIA remifentanil

Vital signs controlled patient assisted intravenous analgesia using remifentanil

Sponsors & Collaborators

  • KK Women's and Children's Hospital

    lead OTHER_GOV

Principal Investigators

  • Wan Ling Leong, MBBS FANZCA · KK Women's & Children's Hospital

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2016-01-31
Completion
2016-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02122705 on ClinicalTrials.gov